Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sourcesS Z Salahuddin, P D Markham, M Popovic, et al.
The American Journal of Pathology|June 17, 1998
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion developmentF Samaniego, P D Markham, R Gendelman, et al.
Nature Medicine|April 1, 1995
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaquesA G Abimiku, G Franchini, J Tartaglia, et al.
Journal of Virology|June 1, 1992
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolatesM Robert-Guroff, K Aldrich, R Muldoon, et al.
Cancer Research|July 1, 1981
Restricted expression of retrovirus nucleic acids and proteins in primate type C virus (gibbon ape leukemia virus-simian sarcoma virus)-initiated human B-lymphoblast culturesP D Markham, F W Ruscetti, V S Kalyanaraman, et al.
The Journal of Experimental Medicine|May 1, 1988
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6)P Lusso, P D Markham, E Tschachler, et al.
The New England Journal of Medicine|December 12, 1985
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complexL Resnick, F diMarzo-Veronese, J Schüpbach, et al.
Science (New York, N.Y.)|October 31, 1986
Isolation of a new virus, HBLV, in patients with lymphoproliferative disordersS Z Salahuddin, D V Ablashi, P D Markham, et al.
AIDS Research and Human Retroviruses|April 9, 1999
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacyM Leno, L Carter, D J Venzon, et al.
AIDS Research and Human Retroviruses|June 29, 2001
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challengeL J Patterson, F Robey, A Muck, et al.
Pageof 7